Warfarin is the most commonly prescribed anticoagulant in the UK and the one most frequently associated with both fatal medication errors and litigation claims [1] . Its life-threatening interactions and side effects are a concern for all doctors. Identifying and implementing solutions to achieve safer prescribing and monitoring is imperative to improve patient safety. The National Patient Safety Agency (NPSA) has outlined the major risks associated with anticoagulant therapy and sought to establish safer practice [1] . The monitoring of safety indicators has been highlighted as a solution. This quality improvement project (QIP) introduces a management algorithm for oral anticoagulant therapy in hospital patients, validated through a completed audit cycle. It was completed at one district general hospital (DGH) in England and involved all inpatient wards. Doctors and pharmacists were interviewed to assess their knowledge of the correct pathways for management of patients on warfarin. The number of errors on hospital warfarin charts was audited over three weeks. These results, coupled with senior haematological advice led to the production of an algorithm illustrating the gold-standard pathway for warfarin management from admission to discharge. It was emailed to all doctors in the Trust and a laminated copy attached to hospital Pneumatic Tube System (PTS) machines. The warfarin charts were reaudited over the following three weeks. The results showed a marked decrease in errors and incomplete anticoagulation referrals as well as a reduction in doctors' anxiety around prescribing warfarin.
Problem
Understanding warfarin management pathways can be challenging, especially for new doctors and trainees moving hospitals on a yearly basis. With no national drug chart and local variations in approach to follow up, management is open to confusion and error.
In the DGH concerned, this was found to be the case, with omissions and errors on the warfarin prescription charts (which doubled as referrals to the anticoagulation clinic) occurring on a daily basis. At this hospital, warfarin was not prescribed on the standard drug chart, but on a separate booklet of pink paper known as a 'warfarin chart' or 'pink form'. Having all sections of this filled out was considered the 'gold standard' in documentation for warfarin prescribing and referral to anticoagulation clinic.
A number of clinical incidents had been highlighted that had compromised patient safety, for example, patients being discharged on warfarin without an appointment to get their International Normalised Ratio (INR) checked. Such incidents had illustrated the serious failures of the current system and its need to be addressed.
The lead biomedical scientist for the anticoagulation clinic remarked in interview, "It is a terrible problem, incomplete or inaccurate warfarin prescriptions are received on a daily basis".
The QIP was carried out in the haematology and biomedical science/anticoagulation departments. Its primary outcome was to find a way to help doctors meet the clinical standards expected of them.
The front page of the warfarin chart had ten information sections to be filled out: Boxes on the back were used for the prescribing of loading and maintenance doses. There were general management guidelines on the inside of the paper, but in a block of text that took time and effort to understand.
The anticoagulation team had been struggling with doctors not completing warfarin charts correctly and had devised a rejection letter entitled, 'Notice of rejection of incomplete referral to anticoagulation clinic', to little effect. They felt they were wasting their time chasing doctors for complete forms, or at worst, rectifying situations that occurred from the poor management of patients.
There had been no formal teaching to explain how to manage 
Background
Most published literature on warfarin relates to pathological consequences rather than quality of care delivered [2] . There was one missed referral to the anticoagulation clinic, described in the 'case example' below.
CASE EXAMPLE
An 87-year-old female, Mrs BA was admitted with shortness of breath. Diagnosed with bilateral pulmonary emboli, she was treated with dalteparin and started on warfarin. During her admission, her
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INR was consistently below range so on discharge she was continued on daily dalteparin injections as well as warfarin. She was given a yellow book and booked into the anticoagulation clinic for the following week but she was not informed about the appointment nor was it documented it in her yellow book. Her warfarin prescription was incomplete with no discharge address, telephone number or concurrent medications. When she failed to attend her appointment, the anticoagulation team were unable to contact her due to this lack of information. After contacting her GP, it was discovered that she had gone to stay with her granddaughter for two weeks post discharge. A district nurse was urgently arranged to collect an INR, which came back as 12.2. She had to receive emergency vitamin K in the community and be re-booked into the next anticoagulation clinic.
Warfarin Management Pathway Intervention"

Design
The baseline results, coupled with advice from a consultant haematologist, led to the production of a flow chart illustrating the correct pathway for warfarin management from admission to discharge, including differences in management between those already on warfarin and those new to it. It directly addressed problems highlighted by the QIP, emphasising the importance of completing the warfarin chart in full. It was also presented in an easy-to-read format, rather than an A4 chunk of text. On the reverse of the flow chart common drugs, foods and herbal preparations that have interactions with warfarin were listed e.g. enzyme inducers and inhibitors. The algorithm and an accompanying letter of explanation were sent to all doctors in the Trust, copies were printed and put up in wards and handover rooms, laminated and stuck to PTS machines. Two weeks after distribution a re-audit took place and the impact was assessed.
Strategy
Problem areas were highlighted in the interviews, particularly regarding the lack of knowledge of the clinical protocol. Many mentioned the ill-defined roles surrounding taking responsibility for full completion of the chart e.g. the person starting the chart or the person discharging the patient. There was a heavy reliance on the anticoagulation team or GPs to make necessary appointments for INR checks rather than, as should have been the case, the discharging doctors arranging these.
Improvement (PDSA) Cycle 1
The design of the algorithm was discussed with consultants, registrars and junior doctors in general medicine and haematology, along with the lead biomedical scientist and other members of the multidisciplinary team working in the anticoagulation clinic.
Improvement (PDSA) Cycle 2
The comments received in the feedback from cycle 1 were taken into account and implemented. The warfarin algorithm was posted up in the doctors mess and feedback welcomed. An example of feedback changing design was the colour scheme of using the same pink paper for the flow chart, as used for the warfarin prescriptions so a clear association between the two was easily achieved. It was also suggested that a copy of the flow chart be given to all new doctors.
Results
After the intervention, the hospital warfarin prescriptions were prospectively re-audited over three weeks to assess the effect of the intervention. The results showed a dramatic reduction in incomplete charts.
In the three week post-intervention audit, there were no inappropriate or missed clinic referrals. 4% (2/47) of prescriptions sent to the anticoagulation clinic were found to have omissions.
Only one chart had major omissions (>5/10 sections blank).
results"
Lessons and Limitations
It has become clear that it is possible to make significant and This requires time to complete e.g. checking creatinine, patient weight or discharge medications.
Responsibility: the doctor who starts the form (often in the medical/surgical admissions unit) is generally not the doctor who discharges the patient. There was no clear assignment of responsibility for completing the form.
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The QIP was cost effective in that its total cost (approximately £34.00 for paper, photocopying and laminating) was less than the cost of one missed outpatient appointment (approximately £156 [5] ), not to mention the legal costs if a serious error were to result in patient harm.
The project was limited by its small sample size, short study period, and re-audit immediately post-intervention. Poor practice could return because of a high turnaround of staff, and so a re-audit one year on is therefore desirable.
It is vital that patient safety remains a priority and hospital practice is constantly reviewed and refined to meet the high standards expected of the NHS. It is everyone's responsibility to be engaged in programmes that work towards improving standards of care.
Implementation of this management algorithm would help standardise management for hospital patients taking anticoagulant drugs, and should reduce morbidity and mortality associated with administration of such medication, from admission, until beyond discharge.
Conclusion
The warfarin management algorithm is a simple, cheap and effective educational intervention that helps to reduce errors in the management of patients on warfarin. It can be implemented in any setting, altered appropriately for each Trust and can be easily saved on smartphones. Educating healthcare professionals on correct management prevents potentially lethal mistakes, decreases prescribers' anxiety regarding correct management, and saves money and time through reducing inappropriate clinic referrals. Until a national prescribing system is designed and implemented, it is particularly important for hospital staff to pay attention to their idiosyncratic systems and design easily understood and readily available instructions for meeting standards.
